跳至主要内容
临床试验/NCT06026904
NCT06026904Enrolling By Invitation不适用

The Effects of Transcutaneous Auricular Vagus Nerve Stimulation on Motivation in Major Depressive Disorder With Anhedonia

Anhui Medical University1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2023年3月30日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
Enrolling By Invitation
发起方
入组人数
60
试验地点
1
主要终点
Change from baseline in Hamilton Depression Scale

研究概览

简要总结

Study of non-invasive transcutaneous auricular vagus nerve stimulation (taVNS) intervention to improve the reward motivation and response inhibition of major depression disorder and its brain network mechanism.

详细描述

Anhedonia is the core symptom of MDD, which means they have deficits in processing rewards.MDD get lesser positive feelings than healthy controls from rewards as they could not use the reward outcome to update the value of a stimulus, which in consequence impedes their reward motivation or response inhibition and worsen their symptom. This study is dedicated to revealing how reward motivation or response inhibition ability could be intervened by taVNS intervention, which has been proven is highly relevant to reward motivation and response inhibition ability. Implementing a safer intervention of taVNS stimulation might help us to prove a better treatment for patients.

All patients underwent a medical evaluation that included physical examination and routine laboratory studies before and after taVNS stimulation treatment. Before and after the taVNS treatment, depression symptom of each participant was assessed by the Hamilton Depression Scale and the Beck Depression Self-Rating Scale. The anhedonia severity was evaluated by The Temporal Experience of Pleasure Scale, the Self-Report Apathy Evaluation Scale, the Positive Valence system scale and the Motivation and Pleasure Scale. The neuroimaging data are collected using event-related potentials during the effort reward task and stop signal task before and after the intervention. Patients were randomly allocated into an active group and a sham group. This study plans to enroll a minimum total sample size of 30 participants in active and sham group respectively according to the Power and Sample Size program. The decision to enroll a patient was always made prior to randomization. Each patient will be treated for 4 weeks with 25Hz taVNS. Each participant was interviewed in detail about the adverse event of the taVNS intervention during 10 days. Every participant should take part in the study voluntarily and sign an informed consent form before the study.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Meet the criteria of depression assessed by at least two psychiatrists according to the fifth version of Diagnostic and Statistical Manual of Mental Disorders.
  • The score of Hamilton Depression Rating Scale-17 is larger than 18 and the score of the Apathy Evaluation scale is lager than
  • Patients were taking antidepressants--Selective Serotonin Reuptake Inhibitor(SSRIs) alone.
  • Age was between 18 to 60 year old. The education duration was at least 6 years.
  • The vision or corrected vision was normal.
  • Right handedness.
  • No treatment of rTMS, transcranial direct current stimulation, or electroconvulsive therapy before.

排除标准

  • History of significant head trauma or neurological disorders.
  • Alcohol or drug abuse.
  • Focal brain lesions.
  • History of seizure.
  • First degree relative with epilepsy, significant neurological illness or head trauma, endocrine disease.
  • Significant unstable medical condition.
  • Recent aggression or other forms of behavioral dyscontrol.
  • Left-handedness.
  • Current alcohol or drug abuse
  • Inability to provide informed consent.
  • Patients with contraindications or factors affecting imaging quality, such as pacemakers, cochlear implants, or hearts Cerebrovascular metal stent, and metal denture.

研究组 & 干预措施

Active Comparator: Real Stimulation

Active Comparator

The active Stimulation of taVNS lasted 30 mins. The stimulation protocol is preset to a biphasic impulse frequency of 25 Hz with a stimulation duration of 30 s, followed by a 30 s off phase. Behavior and ERPs datasets should be acquired before the first taVNS session and after the last taVNS session.The electrical current is transmitted by a titanium electrode placed at the cymba conchae.

干预措施: transcutaneous auricular vagus nerve stimulation (Device)

Sham Comparator: Sham Stimulation

Sham Comparator

The active Stimulation of taVNS lasted 30 mins. The stimulation protocol is preset to a biphasic impulse frequency of 25 Hz with a stimulation duration of 30 s, followed by a 30 s off phase. Behavior and ERPs datasets should be acquired before the first taVNS session and after the last taVNS session.The electrical current is transmitted by a titanium electrode placed at the earlobe of the midpoint of the outer ear margin.

干预措施: transcutaneous auricular vagus nerve stimulation (Device)

结局指标

主要结局

Change from baseline in Hamilton Depression Scale

时间窗: baseline;10days after treatment; 1month and 3 month post-treatment

The participants' depression symptom assessed by the Hamilton Depression Scale change from baseline after the treatment. Score reference value: \<7 points, no depression;7 to 17points, mild depression;18to 24 points, moderate depression; \> 24 points, severe depression. If remission rate reaches 50%, the treatment will be considered effective.

Change from baseline in Apathy Evaluation Scale

时间窗: baseline;10days after treatment; 1month and 3 month post-treatment

The participants' reward motivation assessed by the Apathy Evaluation Scale change from baseline after the treatment. Score reference value: \<37 points, no apathy; ≥37points, apathy. If remission rate reaches 25%, the treatment will be considered effective.

次要结局

  • The change from baseline in behavioral results of effort reward task(baseline;4 weeks post-treatment)
  • The change from baseline in event-related brain potentials during the effort reward task(baseline;4 weeks post-treatment)
  • The change from baseline in behavioral results of stop signal task(baseline;4 weeks post-treatment)
  • The change from baseline in event-related brain potentials during the stop signal task(baseline;4 weeks post-treatment)

研究者

发起方
Anhui Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Fengqiong Yu

Associate Professor

Anhui Medical University

研究点 (1)

Loading locations...

相似试验